Long-Term Use of Supplemental Multivitamins, Vitamin C, Vitamin E, and Folate Does Not Reduce the Risk of Lung Cancer
Christopher G. Slatore1,
Alyson J. Littman2,3,
David H. Au1,4,
Jessie A. Satia5 and
Emily White2,6
1 Division of Pulmonary and Critical Care Medicine, and 2 Department of Epidemiology, University of Washington, Seattle, Washington; 3 Epidemiologic Research and Information Center, and 4 Health Services Research and Development, VA Puget Sound Health Care System, Seattle, Washington; 5 Departments of Epidemiology and Nutrition, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; and 6 Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, Washington
Correspondence and requests for reprints should be addressed to Christopher Slatore, M.D., University of Washington, Division of Pulmonary and Critical Care Medicine, 1959 NE Pacific Street, Box 356522, Seattle, WA 98195-6522. E-mail: cslatore{at}u.washington.edu
Rationale: Lung cancer is the leading cause of cancer-relatedmortality in the United States. Although supplements are usedby half the population, limited information is available abouttheir specific effect on lung cancer risk.
Objectives: To explore the association of supplemental multivitamins,vitamin C, vitamin E, and folate with incident lung cancer.
Methods: Prospective cohort of 77,721 men and women aged 50–76years from Washington State in the VITAL (VITamins And Lifestyle)study. Cases were identified through the Seattle–PugetSound SEER (Surveillance, Epidemiology, and End Results) cancerregistry.
Measurements and Main Results: Hazard ratios (HRs) for incidentlung cancer according to 10-year average daily use of supplementalmultivitamins, vitamin C, vitamin E, and folate. A total of521 cases of lung cancer were identified. Adjusting for smoking,age, and sex, there was no inverse association with any supplement.Supplemental vitamin E was associated with a small increasedrisk of lung cancer (HR, 1.05 for every 100-mg/d increase indose; 95% confidence interval [CI], 1.00–1.09; P = 0.033).This risk of supplemental vitamin E was largely confined tocurrent smokers (HR, 1.11 for every 100-mg/d increase; 95% CI,1.03–1.19; P < 0.01) and was greatest for non–smallcell lung cancer (HR, 1.07 for every 100-mg/d increase; 95%CI, 1.02–1.12; P = 0.004).
Conclusions: Supplemental multivitamins, vitamin C, vitaminE, and folate were not associated with a decreased risk of lungcancer. Supplemental vitamin E was associated with a small increasedrisk. Patients should be counseled against using these supplementsto prevent lung cancer.
Key Words: bronchial neoplasm diet dietary supplements public health
AT A GLANCE COMMENTARY
Scientific Knowledge on the Subject
Lung cancer is the leadingcause of cancer-related mortality in the United States. Althoughsupplements are used by half the population, limited informationis available about their specific effect on lung cancer risk.
WhatThis Study Adds to the Field
Supplemental multivitamins, vitaminC, vitamin E, and folate are unlikely to decrease the risk ofdeveloping lung cancer. Use of supplemental vitamin E at highdoses for a prolonged period of time may slightly increase thisrisk.
Related articles in AJRCCM:
Nutrition and Lung Cancer: Lessons from the Differing Effects of Foods and Supplements
C. G. Slatore, J. W. Chien, D. H. Au, J. A. Satia, and E. White Lung Cancer and Hormone Replacement Therapy: Association in the Vitamins and Lifestyle Study
J. Clin. Oncol.,
March 20, 2010;
28(9):
1540 - 1546.
[Abstract][Full Text][PDF]
M. Ebbing, K. H. Bonaa, O. Nygard, E. Arnesen, P. M. Ueland, J. E. Nordrehaug, K. Rasmussen, I. Njolstad, H. Refsum, D. W. Nilsen, et al. Cancer Incidence and Mortality After Treatment With Folic Acid and Vitamin B12
JAMA,
November 18, 2009;
302(19):
2119 - 2126.
[Abstract][Full Text][PDF]
K. Svennevig RE: "LONG-TERM USE OF {beta}-CAROTENE, RETINOL, LYCOPENE, AND LUTEIN SUPPLEMENTS AND LUNG CANCER RISK: RESULTS FROM THE VITAMINS AND LIFESTYLE (VITAL) STUDY"
Am. J. Epidemiol.,
August 1, 2009;
170(3):
401 - 402.
[Full Text][PDF]
S. Dubey and C. A. Powell Update in Lung Cancer 2008
Am. J. Respir. Crit. Care Med.,
May 15, 2009;
179(10):
860 - 868.
[Full Text][PDF]
Q. Yang, R. M. Bostick, J.M. Friedman, and W. D. Flanders Serum Folate and Cancer Mortality Among U.S. Adults: Findings from the Third National Health and Nutritional Examination Survey Linked Mortality File
Cancer Epidemiol. Biomarkers Prev.,
May 1, 2009;
18(5):
1439 - 1447.
[Abstract][Full Text][PDF]
C. G. Slatore, D. H. Au, A. J. Littman, J. A. Satia, and E. White Association of Nonsteroidal Anti-Inflammatory Drugs with Lung Cancer: Results from a Large Cohort Study
Cancer Epidemiol. Biomarkers Prev.,
April 1, 2009;
18(4):
1203 - 1207.
[Abstract][Full Text][PDF]
J. A. Satia, A. Littman, C. G. Slatore, J. A. Galanko, and E. White Long-term Use of {beta}-Carotene, Retinol, Lycopene, and Lutein Supplements and Lung Cancer Risk: Results From the VITamins And Lifestyle (VITAL) Study
Am. J. Epidemiol.,
April 1, 2009;
169(7):
815 - 828.
[Abstract][Full Text][PDF]
A. E. Dembe Can Moderate Doses of Vitamin E Protect against Lung Cancer?
Am. J. Respir. Crit. Care Med.,
September 15, 2008;
178(6):
653 - 653.
[Full Text][PDF]
C. G. Slatore, D. H. Au, and E. White Can Moderate Doses of Vitamin E Protect against Lung Cancer?
Am. J. Respir. Crit. Care Med.,
September 15, 2008;
178(6):
653 - 654.
[Full Text][PDF]
T. Byers Nutrition and Lung Cancer: Lessons from the Differing Effects of Foods and Supplements
Am. J. Respir. Crit. Care Med.,
March 1, 2008;
177(5):
470 - 471.
[Full Text][PDF]